Global Gastric Inhibitory Polypeptide Receptor Market Study 2016-2026, by Segment (HM-15211, LBT-6030, ), by Market (Metabolic Disorder, Type 2 Diabetes, ), by Company (Alchemia Limited, AstraZeneca Plc, )

October 2019 | 47 pages | ID: GCC373ECACD3EN
99Strategy

Abstracts

SUMMARY

The global Gastric Inhibitory Polypeptide Receptor market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• HM-15211
• LBT-6030
• LY-3298176
• NNC-92041706
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Metabolic Disorder
• Type 2 Diabetes
• Obesity
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Alchemia Limited
• AstraZeneca Plc
• Carmot Therapeutics, Inc.
• Diabetica Limited
• Longevity Biotech, Inc
• Novo Nordisk A/S
• Sanofi
• Zealand Pharma A/S

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Gastric Inhibitory Polypeptide Receptor Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR MARKET BY TYPE

2.1 By Type
  2.1.1 HM-15211
  2.1.2 LBT-6030
  2.1.3 LY-3298176
  2.1.4 NNC-92041706
  2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Metabolic Disorder
  3.1.2 Type 2 Diabetes
  3.1.3 Obesity
  3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Alchemia Limited (Company Profile, Sales Data etc.)
5.2 AstraZeneca Plc (Company Profile, Sales Data etc.)
5.3 Carmot Therapeutics, Inc. (Company Profile, Sales Data etc.)
5.4 Diabetica Limited (Company Profile, Sales Data etc.)
5.5 Longevity Biotech, Inc (Company Profile, Sales Data etc.)
5.6 Novo Nordisk A/S (Company Profile, Sales Data etc.)
5.7 Sanofi (Company Profile, Sales Data etc.)
5.8 Zealand Pharma A/S (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Gastric Inhibitory Polypeptide Receptor Market 2016-2019, by Type, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market 2016-2019, by Type, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, by Type, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, by Type, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Demand 2016-2019, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Demand 2016-2019, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Demand Forecast 2020-2026, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Demand Forecast 2020-2026, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Market Size & Growth 2016-2019, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market Size & Growth 2016-2019, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Market 2016-2019, by Region, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market 2016-2019, by Region, in Volume
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, by Region, in USD Million
Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast 2020-2026, by Region, in Volume
Table Alchemia Limited Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Alchemia Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alchemia Limited Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Alchemia Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Plc Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Carmot Therapeutics, Inc. Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Carmot Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Diabetica Limited Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Diabetica Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Longevity Biotech, Inc Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Longevity Biotech, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zealand Pharma A/S Overview List
Table Gastric Inhibitory Polypeptide Receptor Business Operation of Zealand Pharma A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Gastric Inhibitory Polypeptide Receptor Market Growth 2016-2019, by Type, in USD Million
Figure Global Gastric Inhibitory Polypeptide Receptor Market Growth 2016-2019, by Type, in Volume